↓ Skip to main content

Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease

Overview of attention for article published in Gastroenterology, December 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
12 X users
facebook
1 Facebook page
reddit
2 Redditors
guideline
5 clinical guideline sources

Readers on

mendeley
152 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease
Published in
Gastroenterology, December 2013
DOI 10.1053/j.gastro.2013.12.025
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United Kingdom 4 3%
United States 2 1%
Norway 1 <1%
Spain 1 <1%
Colombia 1 <1%
Unknown 143 94%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 27 18%
Other 20 13%
Student > Postgraduate 17 11%
Student > Master 12 8%
Student > Ph. D. Student 11 7%
Other 33 22%
Unknown 32 21%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 91 60%
Agricultural and Biological Sciences 7 5%
Nursing and Health Professions 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Biochemistry, Genetics and Molecular Biology 2 1%
Other 9 6%
Unknown 35 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2025.
All research outputs
#1,535,237
of 34,457,357 outputs
Outputs from Gastroenterology
#1,708
of 16,860 outputs
Outputs of similar age
#14,056
of 376,171 outputs
Outputs of similar age from Gastroenterology
#20
of 129 outputs
Altmetric has tracked 34,457,357 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,860 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.1. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 376,171 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 129 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.